Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy
Reactivation of cytomegalovirus (CMV) and BK polyomavirus (BKV) can result in virus-associated tubulointerstitial nephritis in renal allografts. All those renal biopsies reported as viral cytopathic were isolated and examined by two independent renal histopathologists from our institute and classifi...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
| Series: | Saudi Journal of Kidney Diseases and Transplantation |
| Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=1;spage=101;epage=106;aulast=Kaul |
| _version_ | 1818507462742900736 |
|---|---|
| author | Anupma Kaul Shashi Kumar Dharmendra Bhaduaria Vinita Agrawal R K Sharma Narayan Prasad Amit Gupta Rishi Kumar |
| author_facet | Anupma Kaul Shashi Kumar Dharmendra Bhaduaria Vinita Agrawal R K Sharma Narayan Prasad Amit Gupta Rishi Kumar |
| author_sort | Anupma Kaul |
| collection | DOAJ |
| description | Reactivation of cytomegalovirus (CMV) and BK polyomavirus (BKV) can result in virus-associated tubulointerstitial nephritis in renal allografts. All those renal biopsies reported as viral cytopathic were isolated and examined by two independent renal histopathologists from our institute and classified as CMV, BKV, and CMV-BKV coinfection-associated viral cytopathic changes with confirmation through polymerase chain reaction technology in either serum or urine or both. All twenty patients were categorized as 10 in CMV, four in BKV, and six were in CMV-BKV coinfection. One patient each had received antithymocyte globulin and basiliximab as induction all patients received triple-drug immunosuppression. The mean graft survival was 69, 61, and 59 months in CMV, BKV, and CMV-BKV coinfection group, respectively. At the end of the study period, 10 (50%) patients died. 1-, 3-and 5-year patient survival was 94%, 88% and 76% among CMV group, 75%, 75% and 50% in BKV group, and 96%, 83% and 62%, in CMV-BKV coinfection group (P = 0.157). CMV and BK virus are not so common infections in postrenal transplant patients yet an important cause of graft dysfunction. Coinfection did not pose an increased risk for acute rejection or patients and death-censored and uncensored graft survival among compared groups |
| first_indexed | 2024-12-10T22:18:43Z |
| format | Article |
| id | doaj.art-a9f96976db334800aaa98faadb650c34 |
| institution | Directory Open Access Journal |
| issn | 1319-2442 |
| language | English |
| last_indexed | 2024-12-10T22:18:43Z |
| publishDate | 2018-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Saudi Journal of Kidney Diseases and Transplantation |
| spelling | doaj.art-a9f96976db334800aaa98faadb650c342022-12-22T01:31:23ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422018-01-0129110110610.4103/1319-2442.225198Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathyAnupma KaulShashi KumarDharmendra BhaduariaVinita AgrawalR K SharmaNarayan PrasadAmit GuptaRishi KumarReactivation of cytomegalovirus (CMV) and BK polyomavirus (BKV) can result in virus-associated tubulointerstitial nephritis in renal allografts. All those renal biopsies reported as viral cytopathic were isolated and examined by two independent renal histopathologists from our institute and classified as CMV, BKV, and CMV-BKV coinfection-associated viral cytopathic changes with confirmation through polymerase chain reaction technology in either serum or urine or both. All twenty patients were categorized as 10 in CMV, four in BKV, and six were in CMV-BKV coinfection. One patient each had received antithymocyte globulin and basiliximab as induction all patients received triple-drug immunosuppression. The mean graft survival was 69, 61, and 59 months in CMV, BKV, and CMV-BKV coinfection group, respectively. At the end of the study period, 10 (50%) patients died. 1-, 3-and 5-year patient survival was 94%, 88% and 76% among CMV group, 75%, 75% and 50% in BKV group, and 96%, 83% and 62%, in CMV-BKV coinfection group (P = 0.157). CMV and BK virus are not so common infections in postrenal transplant patients yet an important cause of graft dysfunction. Coinfection did not pose an increased risk for acute rejection or patients and death-censored and uncensored graft survival among compared groupshttp://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=1;spage=101;epage=106;aulast=Kaul |
| spellingShingle | Anupma Kaul Shashi Kumar Dharmendra Bhaduaria Vinita Agrawal R K Sharma Narayan Prasad Amit Gupta Rishi Kumar Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy Saudi Journal of Kidney Diseases and Transplantation |
| title | Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy |
| title_full | Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy |
| title_fullStr | Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy |
| title_full_unstemmed | Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy |
| title_short | Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy |
| title_sort | outcome of renal transplant recipients with cytomegalovirus and bk polyomavirus co infection nephropathy |
| url | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=1;spage=101;epage=106;aulast=Kaul |
| work_keys_str_mv | AT anupmakaul outcomeofrenaltransplantrecipientswithcytomegalovirusandbkpolyomaviruscoinfectionnephropathy AT shashikumar outcomeofrenaltransplantrecipientswithcytomegalovirusandbkpolyomaviruscoinfectionnephropathy AT dharmendrabhaduaria outcomeofrenaltransplantrecipientswithcytomegalovirusandbkpolyomaviruscoinfectionnephropathy AT vinitaagrawal outcomeofrenaltransplantrecipientswithcytomegalovirusandbkpolyomaviruscoinfectionnephropathy AT rksharma outcomeofrenaltransplantrecipientswithcytomegalovirusandbkpolyomaviruscoinfectionnephropathy AT narayanprasad outcomeofrenaltransplantrecipientswithcytomegalovirusandbkpolyomaviruscoinfectionnephropathy AT amitgupta outcomeofrenaltransplantrecipientswithcytomegalovirusandbkpolyomaviruscoinfectionnephropathy AT rishikumar outcomeofrenaltransplantrecipientswithcytomegalovirusandbkpolyomaviruscoinfectionnephropathy |